Commercially offered · public forecast registry and published review methodology
NextConsensus
Estimates how likely a guideline, label, or coverage decision is to change by a set date.
Now I build AI products the way I built clinical software: identifying unexamined operational assumptions and building systems that eliminate recurring workarounds, from office-number calling at Doximity to runtime agent controls today.
Systems designer and independent researcher · Chicago
Doximity Dialer, which I originated as founding product lead. Doximity’s report for October–December 2025.
I design software and study how the systems we build affect what people can do, what they come to depend on, and how much influence they have over how those systems work. At Doximity, Dialer let a clinician call from a personal phone while the patient saw the office number. Can a tool expand what people can do and their ability to shape how it works at the same time?
Research →Commercially offered · public forecast registry and published review methodology
Estimates how likely a guideline, label, or coverage decision is to change by a set date.
Experimental · open source, with a live demo and a published roadmap
Maps what an agent setup can already do, what one more step would unlock, and which of those tools actually work.
Live · open source, with a scheduled observation bot and a 15,926-event public test set
Refract Replays source revisions to catch a change before the citations that rely on it go stale.
Research and essays
From a first-author ACS Symposium Series chapter on RNA thermodynamics to 230+ essays at The Crumple Zone on how institutions distribute burden, absorb failure, and decide who can exist inside them. Selected writing →
Proposed AI standards
I wrote Ethotechnics’ framework for recording approval, challenges, and corrections. ethotechnics.org
Whether an auditable record can trace a dispute end to end: from an agent action through human challenge to downstream correction.
I take advisory and fractional product leadership roles for healthcare and AI ventures, partner with commercial co-founders on new builds, and research how institutions correct their failures. If you are building something that needs to survive review, or run a system where people are covering for its defects, I would like to hear from you. kanav@kanav.net
Revised